Burgess Chairs House Budget Committee Health Care Task Force Roundtable on Budgetary Effects of Increasing Patient Access to Cell and Gene Therapies
Washington,
July 2, 2024
Washington, D.C. - Congressman Michael C. Burgess, M.D. (R-TX), Chairman of the House Budget Committee Health Care Task Force led a roundtable titled “Paying for 21st Century Cures: Examining the Budgetary Effects of Increasing Patient Access to Cell and Gene Therapies.” During the roundtable Chairman Burgess examined the projected impacts to the federal budget as patient access to innovative cell and gene therapies continues to expand. “We all know the healthcare struggle with budget issues. If we are ever going to move from where we are now to where we should be in the future we have to somehow fix the budget. Modifying genetic material within the patient’s cells and developing personalized treatments were nonexistent before. We passed a big bill in 2016 [21st Century Cures Act], to accelerate new biomedical advancements. Leading up to that law being enacted, we held roundtables all over the country, discussions, and hearings for years leading up to actually passing the legislation and providing the funding for that research, and to streamline the approval process to foster collaboration. Joining Chairman Burgess and Committee members at the roundtable were Chapin White, Director of the Health Analysis Division at the Congressional Budget Office (CBO), Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), Dan Mendelson, Chief Executive Officer of Morgan Health and Mike Capaldi, Executive Director of the Institute for Gene Therapies. Background:
### |
Latest from twitter
Get the most up to date news from me on Twitter.